Clinical Trials Browser

Recruiting × NIH × Sarcoma, Kaposi × Clear all

NCT05907759 2026-03-18

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase 2 Recruiting

LymphoidSarcoma

Multi-centric Castleman's Disease, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, Primary Effusion

NCT07308886 2026-03-18

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Phase 2 Recruiting

LymphoidSarcoma

Lymphoproliferative Disorders, Sarcoma, Kaposi

NCT04902443 2026-03-13

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Phase 1 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT06375122 2026-03-04

Natural History Study of Kaposi Sarcoma

Sarcoma, Kaposi

NCT00006518 2026-02-25

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Lymphoma, Neoplasms, Sarcoma, Kaposi, Virus Diseases, Lymphoma, Primary Effusion

NCT03300830 2026-02-05

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Castleman Disease, Immunologic Deficiency Syndromes, Sarcoma, Kaposi

NCT04941274 2026-01-23

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Phase 1/2 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT04303117 2025-08-22

NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Phase 1/2 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi